DSGN
Design Therapeutics
Stock NASDAQ – Stock Market Prices, News & Analysis
Design Therapeutics Inc est engagée dans le développement de thérapies génomiques pour le traitement de maladies génétiques graves.
Design Therapeutics
DSGN
Design Therapeutics Inc est engagée dans le développement de thérapies génomiques pour le traitement de maladies génétiques graves.
Price history of Design Therapeutics
Price history of Design Therapeutics
Performance & Momentum
Strategic Analysis
Design Therapeutics • 2026
Design Therapeutics Inc is positioned in the highly specialized sector of gene therapies, targeting severe genetic diseases. Its model is based on biotechnology innovation with advanced expertise in designing personalized treatments.
Strengths
- Specialization in a rapidly growing segment with a strong unmet medical need
- Exceptional recent performance reflecting increasing market interest
- U.S. position benefiting from a mature and dynamic biotech ecosystem
Weaknesses
- Marked historical volatility with a significant decline over five years
- Lack of recent news likely to support short-term visibility
Momentum
Momentum is very positive, supported by robust annual and semi-annual performances, indicating a resurgence of investor interest. This favorable dynamic suggests better recognition of the company's innovative potential in a demanding sector.
Similar stocks to Design Therapeutics
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
